-
The Rise of Muscle-Building Therapies: A Promising Frontier in Biotechnology
As Eli Lilly, the leading pharmaceutical company globally, continues to make strategic moves in the field, it serves as a crucial benchmark for intern...
2023-11-22 18:29 -
Merck to Acquire Caraway Therapeutics in a $610 Million Deal
Pharmaceutical giant Merck announced on November 21st that it has reached an agreement to acquire Caraway Therapeutics, a biotechnology company specia...
2023-11-22 18:21 -
Rapid Commercialization of Fruquintinib in the Treatment of Metastatic Colorectal Cancer: A New Benc...
On November 9th, the U.S. Food and Drug Administration (FDA) approved the use of fruquintinib, developed by Hengrui Medicine and Takeda, for the treat...
2023-11-22 18:08 -
Fruquintinib's Swift Commercialization Sets a New Benchmark for Chinese Innovative Drugs Going Globa...
On November 9th, the U.S. Food and Drug Administration (FDA) granted approval for the use of fruquintinib, developed by Hengrui Medicine and licensed ...
2023-11-22 17:28 -
The Growing Market Potential of GLP-1 Drugs in China's Obesity and Diabetes Landscape
China has emerged as the country with the highest number of obese individuals worldwide.
2023-11-21 16:58 -
Usynova Partners with AstraZeneca for KRASG12D Inhibitor UA022 in Global Development and Commerciali...
Usynova announced a licensing agreement with AstraZeneca for the clinical-stage small molecule KRASG12D inhibitor UA022. Under the agreement, AstraZen...
2023-11-21 16:34 -
Edivirine Tablets Included in Priority Review List for Expanded Indication
On November 20th, CDE (China Drug Evaluation) announced that Edivirine tablets, developed by Jiangsu Addy Pharmaceutical Co., Ltd. (hereinafter referr...
2023-11-21 16:29 -
Advancements in the Treatment of Pancreatic Ductal Adenocarcinoma: A Look at Emerging Therapies
Pancreatic ductal adenocarcinoma (PDAC) is a challenging malignancy with limited treatment options.
2023-11-21 15:43 -
The Potential Breakthrough in Pancreatic Cancer Treatment: Unveiling the Challenges and Promising Ad...
Market discussions surrounding the sharp decline in the stock price of Alphamab Onc. have shed light on the potential connection to the unblinding of ...
2023-11-21 14:30 -
Breakthrough Medications in 2023: Advancements in Healthcare
The year 2023 has witnessed remarkable advancements in the field of medicine, with the introduction of breakthrough medications that address critical ...
2023-11-20 18:12
Hot News
- 关于进一步规范化学品信息发布、... Jan 27, 2026
- BASF’s 2025 Report Card—“Th... Jan 27, 2026
- Invista Reshuffles Global Nylo... Jan 28, 2026
- 5%–10% Is Just the Surface: B... Jan 15, 2026
- “Europe’s Chemical Industry ... Feb 02, 2026
Related Products
Related Producers
